Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers

Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells

B2 miceta-roglobulin knockout K562 cell-based artificial antigen presenting cells for ex vivo expansion of T lymphocytes

Zha S, Li Z, Chen C, Du Z, Tay JC, Wang S

Immunotherapy 2019, 11: 967

https://www.futuremedicine.com/doi/abs/10.2217/imt-2018-0211